← Volver a resultados
Ficha bibliográfica · Consulta y acceso
Artículo

A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline

Mingfang Jia et al · SpringerOpen · 2026

Acceso abierto disponible
Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto disponible

Recurso identificado como acceso abierto, sin confirmar automáticamente si es texto completo directo.
Abrir recurso

Resumen

Descripción general del contenido del recurso.

Abstract Objective Financial toxicity, characterized by the financial burden and psychological distress associated with cancer treatment, has become a critical issue impacting patient outcomes and quality of life. This study aimed to conduct an updated and comprehensive systematic review to evaluate the methodological quality and measurement properties of financial toxicity measurement instruments for cancer patients, thereby guiding the selection of high-quality tools for future empirical research. Methods Literature on financial toxicity measurement instruments for cancer patients was retrieved from CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, CINAHL, Scopus, and Embase databases, with a search range from the inception up to April 16, 2025. Two researchers independently screened the literature and extracted data. The included studies were assessed using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN), and recommendations were formulated based on the quality of evidence and measurement properties. Results A total of eighteen studies were included, involving eight financial toxicity measurement instruments for cancer patients. None of the studies reported measurement error. The Comprehensive Score for Financial Toxicity (COST), Financial Index of Toxicity (FIT), and Subjective Financial Distress Questionnaire (SFDQ) were provisionally recommended for use (Category B), while the other five instruments were not recommended due to insufficient evidence (Category C). Conclusion The COST is provisionally recommended for measuring financial toxicity in cancer patients. The methodological quality and measurement properties of existing financial toxicity instruments still require further improvement. Future research should adhere strictly to the COSMIN guideline to validate existing tools or develop new, high-quality instruments with comprehensive evaluations of their measurement properties.

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, M. J. E. (2026). A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline. https://doi.org/10.1186/s41687-026-01042-z

MLA

al, Mingfang Jia et. "A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline." 2026. https://doi.org/10.1186/s41687-026-01042-z.

Chicago

al, Mingfang Jia et. 2026. "A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline.". https://doi.org/10.1186/s41687-026-01042-z.

Harvard

al, M. J. E. 2026, A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline, SpringerOpen, available at: https://doi.org/10.1186/s41687-026-01042-z [Accessed 29 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título
A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline
Autor / colaboradores
Mingfang Jia et al
Editorial
SpringerOpen
Año de publicación
2026
ISSN
2509-8020
ISSN
2509-8020
Idioma
eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

Copiado